Abstract
Modern treatments cure most testicular cancer patients so an important goal is to minimise toxicity. We have undertaken a cross-sectional study to evaluate the quality of life (Qol) of long-term survivors of testicular cancer. Six hundred and fify four patients treated between 1982 and 1992 completed the EORTC Qly-C-30 (QC30) questionnaire, the associated testicular cancer specific module and a general health and fertility questionnaire. Patients have been subdivided according to treatment received: orchidectomy either alone (surveillance, S), with chemotherapy only (C), radiotherapy only (R), or both chemotherapy and radiotherapy (C/RT).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag London Limited
About this paper
Cite this paper
Huddart, R.A. et al. (2002). Fertility and Quality of Life after Treatment for Testicular Cancer. In: Harnden, P., Joffe, J.K., Jones, W.G. (eds) Germ Cell Tumours V. Springer, London. https://doi.org/10.1007/978-1-4471-3281-3_46
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3281-3_46
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3283-7
Online ISBN: 978-1-4471-3281-3
eBook Packages: Springer Book Archive